ES8605769A1 - Un procedimiento para la preparacion de un peptido - Google Patents
Un procedimiento para la preparacion de un peptidoInfo
- Publication number
- ES8605769A1 ES8605769A1 ES542212A ES542212A ES8605769A1 ES 8605769 A1 ES8605769 A1 ES 8605769A1 ES 542212 A ES542212 A ES 542212A ES 542212 A ES542212 A ES 542212A ES 8605769 A1 ES8605769 A1 ES 8605769A1
- Authority
- ES
- Spain
- Prior art keywords
- peptides
- image
- leu
- lys
- formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 2
- 125000000539 amino acid group Chemical group 0.000 abstract 1
- 230000001003 psychopharmacologic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/16—Oxytocins; Vasopressins; Related peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1021—Tetrapeptides with the first amino acid being acidic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S930/00—Peptide or protein sequence
- Y10S930/01—Peptide or protein sequence
- Y10S930/15—Oxytocin or vasopressin; related peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Psychiatry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pain & Pain Management (AREA)
- Anesthesiology (AREA)
- Hospice & Palliative Care (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
PROCEDIMIENTO PARA LA OBTENCION DE UN PEPTIDO Y DE SUS DERIVADOS FUNCIONALES, DE FORMULA (I), EN LA QUE A REPRESENTA ARG, LIS, O LEU Y R REPRESENTA EL GRUPO HL-CIS-OH O H-L-ASX-L-CIS-L-PRO-L-A-OH. CONSISTE EN LA ELIMINACION DE LOS GRUPOS PROTECTORES O EL VEHICULO EN FASE SOLIDA EN EL PEPTIDO DE FORMULA (II), EN LA QUE R TIENE EL MISMO SIGNIFICADO QUE EN LA FORMULA (I) Y B, Q Y A PUEDEN SER VARIOS TIPOS DE RADICALES, Y EN EL QUE SI Q NO REPRESENTA UN VEHICULO EN FASE SOLIDA, HAY AL MENOS UN GRUPO PROTECTOR. LA ELIMINACION DE LOS GRUPOS PROTECTORES SE EFECTUA SIGUIENDO METODOS CONVENCIONALES EN CADA CASO, Y LA SEPARACION DEL VEHICULO SE PUEDE HACER CON ACIDO TRIFLUORMETANOSULFONICO. ESTOS PEPTIDOS TIENEN APLICACIONES FARMACOLOGICAS POR SU INFLUENCIA SOBRE LOS PROCESOS DE LA MEMORIA.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NL8401187 | 1984-04-13 |
Publications (2)
Publication Number | Publication Date |
---|---|
ES8605769A1 true ES8605769A1 (es) | 1985-12-16 |
ES542212A0 ES542212A0 (es) | 1985-12-16 |
Family
ID=19843805
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES542212A Granted ES542212A0 (es) | 1984-04-13 | 1985-04-12 | Un procedimiento para la preparacion de un peptido |
Country Status (13)
Country | Link |
---|---|
US (1) | US4623640A (es) |
EP (1) | EP0161017B1 (es) |
JP (1) | JPS60231697A (es) |
KR (1) | KR870001145B1 (es) |
AU (1) | AU574154B2 (es) |
CA (1) | CA1250400A (es) |
DE (1) | DE3560261D1 (es) |
DK (1) | DK166154C (es) |
ES (1) | ES542212A0 (es) |
FI (1) | FI85275C (es) |
HU (1) | HU192206B (es) |
IE (1) | IE58407B1 (es) |
ZA (1) | ZA852535B (es) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1238314A (en) * | 1983-09-22 | 1988-06-21 | James F. Callahan | Process for preparing basic heptapeptide vasopressin antagonists |
US4748154A (en) * | 1985-12-24 | 1988-05-31 | Takeda Chemical Industries, Ltd. | Peptide derivatives, their production and use |
JP2542241B2 (ja) * | 1988-08-12 | 1996-10-09 | 富士レビオ株式会社 | ペプチド |
ATE113606T1 (de) * | 1989-04-15 | 1994-11-15 | Nippon Chemiphar Co | Peptide und diese peptide enthaltende wirkstoffe gegen dementia. |
DK53191D0 (da) * | 1991-03-25 | 1991-03-25 | Carlbiotech Ltd As | Organosvovlforbindelse og farmaceutisk praeparat indeholdende en saadan forbindelse |
GB2269821B (en) * | 1992-08-08 | 1996-06-05 | Shanghai Inst Biochemistry | Memory enhancing peptides and pharmaceutical compositions containing them |
CN1154656C (zh) * | 2000-06-30 | 2004-06-23 | 上海中科英泰生物技术有限公司 | 一类记忆增强肽和它们的用途 |
US7402157B2 (en) * | 2001-12-19 | 2008-07-22 | The Procter & Gamble Company | Absorbent article having perception of depth |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CS171787B1 (es) * | 1973-11-09 | 1976-11-29 | ||
IE56021B1 (en) * | 1982-10-13 | 1991-03-27 | Akzo Nv | Peptides |
-
1985
- 1985-04-01 IE IE82985A patent/IE58407B1/en not_active IP Right Cessation
- 1985-04-03 EP EP85200512A patent/EP0161017B1/en not_active Expired
- 1985-04-03 ZA ZA852535A patent/ZA852535B/xx unknown
- 1985-04-03 DE DE8585200512T patent/DE3560261D1/de not_active Expired
- 1985-04-08 US US06/720,704 patent/US4623640A/en not_active Expired - Fee Related
- 1985-04-10 JP JP60076322A patent/JPS60231697A/ja active Pending
- 1985-04-11 AU AU41012/85A patent/AU574154B2/en not_active Ceased
- 1985-04-12 ES ES542212A patent/ES542212A0/es active Granted
- 1985-04-12 KR KR1019850002458A patent/KR870001145B1/ko not_active IP Right Cessation
- 1985-04-12 HU HU851373A patent/HU192206B/hu not_active IP Right Cessation
- 1985-04-12 CA CA000478958A patent/CA1250400A/en not_active Expired
- 1985-04-12 DK DK165885A patent/DK166154C/da not_active IP Right Cessation
- 1985-04-12 FI FI851488A patent/FI85275C/fi not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
EP0161017A1 (en) | 1985-11-13 |
IE58407B1 (en) | 1993-09-22 |
HUT37804A (en) | 1986-02-28 |
FI85275C (fi) | 1992-03-25 |
US4623640A (en) | 1986-11-18 |
DE3560261D1 (en) | 1987-07-23 |
EP0161017B1 (en) | 1987-06-16 |
KR870001145B1 (ko) | 1987-06-11 |
DK166154C (da) | 1993-08-09 |
IE850829L (en) | 1985-10-13 |
DK166154B (da) | 1993-03-15 |
AU4101285A (en) | 1985-10-17 |
FI85275B (fi) | 1991-12-13 |
ZA852535B (en) | 1985-11-27 |
AU574154B2 (en) | 1988-06-30 |
FI851488L (fi) | 1985-10-14 |
CA1250400A (en) | 1989-02-21 |
DK165885A (da) | 1985-10-14 |
KR850007802A (ko) | 1985-12-09 |
DK165885D0 (da) | 1985-04-12 |
JPS60231697A (ja) | 1985-11-18 |
HU192206B (en) | 1987-05-28 |
ES542212A0 (es) | 1985-12-16 |
FI851488A0 (fi) | 1985-04-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES8501364A1 (es) | Un metodo para la preparacion de nuevos polipeptidos. | |
JO2034B1 (en) | Isotopes of the hormone peptide its uses and the chemical compounds it contains | |
AU571225B2 (en) | Retro-inverso analogues of the bradykinin potentiating peptide bpp 5a | |
DE3169160D1 (en) | Amino-acids derivatives and their therapeutic use | |
CA2110693A1 (en) | Amino acid derivative anticonvulsant | |
MX9500072A (es) | Compuestos con propiedades de liberacion de la hormona del crecimiento. | |
DK0728148T3 (da) | Forbedrede immunogene sammensætninger mod humant gastrin 17 | |
GR3034924T3 (en) | Novel peptide derivatives | |
EP0254080A3 (en) | Malonic acid derivatives and methods for their synthesis | |
GR3033661T3 (en) | Novel mercaptoacetylamido 1,3,4,5-tetrahydro-benzo(c)azepin-3-one disulfide derivatives useful as inhibitors of enkephalinase and ace | |
EP0662516A4 (en) | NEW ELAFINE DERIVATIVE. | |
ES8706654A1 (es) | Un procedimiento para la preparacion de nuevos derivados de benzotiazina | |
ES8605769A1 (es) | Un procedimiento para la preparacion de un peptido | |
CA2020838A1 (en) | Hemoregulatory peptides | |
YU12000A (sh) | Supstituisani 1,2,3,4,5,6-heksahidro-2,6-metano-3-benzazocin -10-oli, postupak za njihovo pripremanje i njihova primena kao lekova | |
GR852541B (es) | ||
ES8304919A1 (es) | Un procedimiento para la preparacion de dicloroamino-acidos. | |
NZ279396A (en) | Octahydro-6-hetring[2,1-a][2]benzazepine disulphide derivatives | |
GB9324931D0 (en) | Glutaramide derivatives | |
IL80804A (en) | Process for the preparation of peptides by use of perchlorates | |
MY106274A (en) | Sdk peptides, a preparation process of the same and therapeutic compositions containing them. | |
DE3855751D1 (en) | Hypoglycemische peptide | |
AP9400608A0 (en) | "New nicotinic acid derivative". | |
EP1840134A3 (en) | GLP-1 derivatives | |
UA16247A1 (uk) | N-(3-ХЛОРО-1,4-HАФТОХІHОHІЛ-2)-2-Д, alРha-АСПАРАГІHОВУ КИСЛОТА, ЩО ПРОЯВЛЯЄ КАРДІОСТИМУЛЮЮЧІ ВЛАСТИВОСТІ |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FD1A | Patent lapsed |
Effective date: 19970519 |